Skip to content

Clinical trials

Phase 2 Liposarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liposarcoma Phase: Phase 2 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20033
20041
20051
20064
20073
20081
20102
20125
20131
20143
20154
20165
20173
20181
20193
20203
20212
20224
20233
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Active, not recruiting9
Recruiting7
Terminated6
Unknown status6
Withdrawn4
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
European Organisation for Research and Treatment of Cancer - EORTC6
Memorial Sloan Kettering Cancer Center6
Dana-Farber Cancer Institute3
Alliance for Clinical Trials in Oncology2
Brown University2
Fudan University2
Gustave Roussy, Cancer Campus, Grand Paris2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
M.D. Anderson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liposarcoma71
Sarcoma49
Leiomyosarcoma35
Histiocytoma, Malignant Fibrous28
Hemangiosarcoma23
Sarcoma, Synovial23
Fibrosarcoma22
Neurofibrosarcoma18
Rhabdomyosarcoma16
Dermatofibrosarcoma11

Trials

Showing 26 to 50 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.